Literature DB >> 7517093

The visual outcome of peripapillary choroidal neovascular membranes.

S Ruben1, H Palmer, R J Marsh.   

Abstract

Twenty eyes with age related peripapillary choroidal neovascular membranes were studied retrospectively to establish visual outcome in relation to treatment with argon laser, position and size. There was no statistical difference in final visual acuity in relation to laser treatment, size of membrane, nor position of the membrane at presentation. Despite these findings, there is evidence that laser treatment may delay the progression of visual loss.

Entities:  

Mesh:

Year:  1994        PMID: 7517093     DOI: 10.1111/j.1755-3768.1994.tb02749.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  5 in total

1.  Surgical treatment of peripapillary choroidal neovascularisation.

Authors:  Susanne Binder
Journal:  Br J Ophthalmol       Date:  2007-08       Impact factor: 4.638

2.  Prevalence of peripapillary choroidal neovascular membranes (PPCNV) in an elderly UK population-the Bridlington eye assessment project (BEAP): a cross-sectional study (2002-2006).

Authors:  Craig Wilde; Ali Poostchi; Rajnikant L Mehta; Jonathan G Hillman; Hamish K MacNab; Marco Messina; Gaspare Monaco; Stephen A Vernon; Winfried M Amoaku
Journal:  Eye (Lond)       Date:  2018-10-12       Impact factor: 3.775

3.  Surgical treatment of peripapillary choroidal neovascularisation.

Authors:  S Aisenbrey; F Gelisken; P Szurman; K U Bartz-Schmidt
Journal:  Br J Ophthalmol       Date:  2007-02-14       Impact factor: 4.638

Review 4.  Treating peripapillary choroidal neovascular membranes: a review of the evidence.

Authors:  G Jutley; G Jutley; V Tah; D Lindfield; G Menon
Journal:  Eye (Lond)       Date:  2011-03-11       Impact factor: 3.775

5.  Idiopathic Peripapillary Subretinal Neovascular Membrane in a Young Woman with Recurrence of the Lesion during Pregnancy after Treatment with Intravitreal Bevacizumab.

Authors:  Nasra Al-Gharbi; Omar Al Abdulsalam; Ahmed Al Habash
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.